Objective. Findings regarding small nerve fiber damage in complex regional pain syndrome type I (CRPS-I) are not uniform, and studies have not included a matched healthy control group. The aim was to assess intraepidermal nerve fiber density (IENFD) in relation to thermal sensitivity of the same skin areas in CRPS-I patients and a genderand age-matched healthy control group.
Introduction
The pathophysiology of complex regional pain syndrome (CRPS) is poorly understood. Multiple mechanisms may include neuro-immune interactions, exaggerated neurogenic inflammation, and changes in sympathetic function and central pain modulation [1] [2] [3] [4] [5] [6] [7] [8] [9] . CRPS can be differentiated by the absence (CRPS-I) or presence (CRPS-II) of major nerve lesions [10] . The most common inciting events of CRPS-I are bone or soft tissue injury V C 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com [11, 12] , but the condition may spread to additional sites such as the contralateral limb [13] [14] [15] [16] .
The clinical similarity between CRPS-I and CRPS-II and the post-traumatic onset of CRPS-I have led to the hypothesis that small nerve fiber damage contributes to CRPS-I [17] [18] [19] [20] . Using electron microscopy [20] , the histopathology of peripheral nerves was investigated in eight CRPS-I patients and age-matched patients with degenerative disease (without evidence of peripheral neuropathy). C-fiber pathology (denervated parallel Schwann cell stacks, miniature axon sprouts, and an increase of collagen pockets) and decreased myelin density were identified in the sural nerve in 50% of the CRPS-I patients. However, no healthy control group was included, and only amputation tissue was investigated. Albrecht et al. [17] also found several neuropathological alterations detected by immunofluorescence antibodies against neural-related proteins and mediators in skin from amputated CRPS-I extremities. However, only two patients (one upper extremity CRPS-I patient and one lower extremity CRPS-I patient) were included, and the study lacked appropriate controls as control skin was taken from only upper extremities of five healthy individuals. In a study of skin from nonamputated CRPS-I patients [18] , decreased small fiber axonal density was found at the CRPS-affected site in 17 of 18 patients compared with unaffected ipsilateral and contralateral sites. Again, no healthy control group was included. To our knowledge, only one study has compared skin biopsies from CRPS patients with a larger healthy control group. Kharkar et al. [19] compared 43 CRPS-I patients with a normative data set. Approximately 20% of the CRPS-I patients had intraepidermal nerve fiber density (IENFD) below the fifth percentile cutoff value, indicating skin innervation changes. Nevertheless, age and gender were not controlled, despite findings that nerve fiber density differs between genders and across ages [21, 22] .
Small fiber neuropathy (SFN) is associated with abnormal thermal detection thresholds [23] . In a multicenter study of 416 CRPS-I patients [24] , 39% of patients had reduced cold and warmth sensation in their affected limb. In another sample of 43 CRPS-I patients, Kharkar et al. [19] found abnormal warmth detection thresholds in 34% of patients and abnormal cold detection thresholds in 23% of patients. However, this study raises doubts about the validity of using thermal threshold assessments alone for SFN detection as IENFD did not correlate with thermal detection thresholds. Findings in other patient groups are also inconsistent regarding the validity of thermal thresholds for the detection of SFN [25] [26] [27] [28] [29] [30] .
We wanted to determine whether small fiber damage (estimated by IENFD) is present in affected and unaffected skin of CRPS-I patients when compared with similar skin in age-and gender-matched healthy controls. Furthermore, we wanted to compare structural findings with thermal sensory measures of the same skin area.
Methods

Participants
Eight CRPS-I patients (seven females, one male, mean age 45.5 6 5.19 years, six upper limb, two lower limb) who fulfilled research criteria for CRPS-I [31] were recruited from the Danish Pain Clinic, Department of Neurology, Aarhus University Hospital, Denmark. Sensory, autonomic, and motor disturbances were reported by patients and noted during a physical examination (Table 1) . Exclusion criteria were age 17 years or younger, a second chronic pain syndrome, psychiatric comorbidity, pain in both hands or both feet, pregnancy or breastfeeding, sympathectomy in the affected limb, and hypertension. Furthermore, patients with injury to a major peripheral nerve, thus classifying them as CRPS-II, were excluded. Five of the CRPS-I patients were taking regular medication to control their pain. These included paracetamol (three patients), antidepressants (three patients), antiepileptics (two patients), nonsteroidal anti-inflammatory drugs (one patient), and morphine-like medications (tramadol, buprenorphine, methadone; three patients). Patients were asked to abstain from medication on the day of assessment. However, one patient took her early morning dosage of methadone and venlafaxine (seven hours before assessment). All healthy controls were individually matched to the patients by gender and age 65 years (seven females, one male, mean age 46.9 6 4.83 years) and by handedness. The study was approved by the local ethics committee, and informed consent was obtained from each participant.
Skin Biopsies
Skin biopsies were taken from the site of most severe hyperalgesia/allodynia on the dorsal site of the affected limb and at an equivalent site on the contralateral unaffected limb. For ethical reasons, biopsies were taken from only one limb in the healthy controls at the site corresponding to the affected limb of the matching patient. Under local anesthesia (1 mL lidocaine), 3-mm punch skin biopsies were taken from each site under sterile conditions using a disposable punch (Miltex, York, PA, USA).
Analysis of the Skin Biopsies
The biopsies were fixed in 2% paraformaldehyde-lysineperiodate overnight and cryo-protected in 20% glycerol and 0.08 M Sorenses PO4 buffer. The biopsies were subsequently cut into 50-lm thick cryostat sections, vertically to the direction of the epidermis, and three random sections were immunoreacted with PGP 9.5 antibody (rabbit antihuman 1:10.000, abD Serotec, Dü sseldorf, Germany), as described elsewhere [32] . Signs of disturbances documented during a physical examination are shown in boldface. A blank space designates a lack of that specific symptom. During the physical examination, the extent of hyperalgesia and allodynia in the symptomatic and the contralateral healthy limb was assessed. Sharpness to a single application of the neurotip of a neuropen (Owen Mumford) was rated on a scale from 0 (not sharp) to 10 (stabbing). A sharpness rating of at least 2 more points in the affected than the unaffected limb was regarded as hyperalgesia. Patients also rated the sensation of three or four light backwards-forwards strokes with a small brush as a normal or abnormal sensation. Descriptions of the brushing as uncomfortable, scratching, or painful were defined as allodynia. In terms of vasomotor and sudomotor disturbances, patients reported asymmetrical temperature sensations, dyschromia, and hyperhidrosis. Limb temperature was also assessed during the physical examination after the patient had rested quietly for at least 20 minutes (room temperature 22 6 2 C). The temperature of the first phalanx of each toe was determined in lower limb CRPS patients, while the equivalent was obtained in the fingers of patients with upper limb pain using an infrared skin thermometer. This was done in both the symptomatic limb and the equivalent healthy limb. A temperature difference of more than 1 C was defined as asymmetrical (e.g., a hot or cold limb) and is shown in boldface. 
Bilaterally Reduced Intraepidermal Nerve Fiber Density in Unilateral CRPS-I
Protein gene product 9.5 (PGP 9.5) is a pan-neuronal marker that is expressed on all types of nerve fibers.
Microscopal analysis was performed with Olympus BX51, an Olympus DP70 camera (Olympus, Tokyo, Japan), a Heidenhain ND 281 encoder, and a Prior Proscan II motorized stage, and the IENFD was determined following guidelines from the European Federation of Neurological Societies [33] in a blinded fashion. Only PGP 9.5-positive nerve fibers crossing the epidermal-dermal layer (basal membrane) were counted, thus excluding nerve fibers visible only in either the epidermis or dermis.
Sensory Tests
All sensory tests were performed prior to the skin biopsies in a room maintained at 22 6 2 C. They were performed in random order on both hands (in upper limb patients and their matched controls) or both feet (in lower limb patients and their matched controls). The test sites were equivalent to the biopsy sites on both the affected and unaffected limbs and equivalent sites in the healthy controls.
Thermal Thresholds
The cold detection threshold, warm detection threshold, cold pain threshold, and heat pain threshold were determined using the method of limits. Thermal stimuli were delivered via a Medoc TSA II (Ramat Yishai, Israel). The starting temperature was 32 C, ramp rates were 1 C/ sec, and safety cutoffs were 50 C and 5 C. After the thermode surface (9 cm 2 ) was placed in full contact with the skin, sufficient time was allowed for adaptation to the neutral starting temperature so that the thermode felt neither cold nor warm. The participant pressed a response button when the first instance of temperature change or pain was felt. The order of testing for each participant was as follows: cold detection threshold (two trials), warm detection threshold (two trials), cold pain threshold (one trial), and heat pain threshold (one trial). However, limb order was randomized.
Thermal Ratings
Participants rated sensations of cold (cool rating [CR] ) and pain (cold pain rating [CPR]) to a 5 C metal bar (diameter 1 cm 2 , seven-second duration) on a scale from 0 (not cold/no pain) to 10 (extremely cold/extremely severe pain). Similarly, participants rated sensations of warmth (warm rating [WR] ) and pain (heat pain rating [HPR] ) to a 40 C metal bar (Rolltemp by Somedic, Sollentuna, Sweden; seven-second duration) on a scale from 0 (not warm/no pain) to 10 (extremely warm/extremely severe pain).
Statistical Approach
IBM SPSS Statistics 21, a widely used and accepted statistical software program in the social and health sciences, was used to analyze data. The variables were tested for normality using the Kolmogorov-Smirnov test. Thermal sensitivity was similar in both limbs of controls. Therefore, mean scores across both limbs were calculated to increase reliability. As the samples were small and the distribution of some of the variables differed from normal, differences between patients and controls were investigated with the Mann-Whitney U test, and differences between the affected and unaffected limbs of patients were investigated with Wilcoxon's signedranks test. Spearman's rho was used for correlational analysis. The criterion of statistical significance was a P value of less than .05, and results are reported as the median 6 interquartile range.
Results
Skin Biopsies
IENFD was significantly higher in controls (14.50 6 4.06/ mm) than in the CRPS-affected limb (3.55 6 2.39/mm, Mann-Whitney U test P < 0.001) and contralateral unaffected limb of patients (2.80 6 4.02/mm, Mann-Whitney U test P < 0.001). The IEFND was similar in the affected and contralateral limbs of patients ( Figure 1 ) and was Figure 1 Quantification of intraepidermal nerve fiber density in healthy controls and in the affected limb and the contralateral unaffected limb of CRPS-I patients. Each dot represents data from one participant, and the horizontal line in each column represents the median. ***P < 0.001 compared with controls (Mann-Whitney U test).
lower than the fifth percentile cutoff value for HCs (11.84/mm) in both limbs of all eight CRPS-I patients.
The duration of symptoms (months) was not correlated with IENFD in the affected or contralateral limbs of patients.
Thermal Thresholds
The heat pain threshold was lower in the affected limb of CRPS-I patients than in healthy controls (35.6 6 3.8 C vs 38.4 6 2.8 C, Mann-Whitney U test P < 0.05). All other thermal thresholds were similar in patients and controls, and in the affected and unaffected limbs of CRPS-I patients (Figure 2 ).
Thermal Ratings
In general, CRPS-I patients rated the cold bar as colder and the warm bar as hotter than the healthy controls ( Figure 3) . Specifically, cold ratings were higher for the CRPS-affected limb than in controls (7.0 6 4.0 vs 2.5 6 2.8, Mann-Whitney U test P < 0.01). Similarly, heat ratings were higher for the CRPS-affected limb than in controls (7.0 6 4.3 vs 2.8 6 2.0, Mann-Whitney U test P < 0.01). In addition, heat ratings were higher for the unaffected limb of CRPS-I patients than in controls (5.5 6 1.8 vs 2.8 6 2.0, Mann-Whitney U test P < 0.05).
CRPS-I patients also reported significantly greater pain to the cold bar than healthy controls (Figure 3) . Specifically, cold pain ratings were higher for the Figure 2 Cold detection thresholds (A), cold pain thresholds (B), warm detection thresholds (C), and heat pain thresholds (D) in healthy controls and in the affected limb and the contralateral unaffected limb of CRPS-I patients. Each dot represents data from one participant, and the horizontal line in each column represents the median. *P < 0.05 compared with controls (Mann-Whitney U test).
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CRPS-affected limb than the unaffected limb (7.0 6 7.1 vs 0 6 1.8, Wilcoxon signed-ranks test P < 0.05) and higher for the CRPS-affected limb than in controls (7.0 6 7.1 vs 0 6 0.8, Mann-Whitney U test P < 0.01). A similar trend for heat pain ratings did not achieve statistical significance.
Discussion
Bilateral Small Fiber Pathology in CRPS-I
The main finding of the present study was that IENFD was significantly lower in both limbs of CRPS-I patients compared with healthy controls. Indeed, the IENFD was lower than the fifth percentile cutoff value for healthy controls in both limbs of all eight patients, underlining the significant small fiber reduction in the patients. Thus, small fiber loss seemed to be present bilaterally in all of the CRPS patients.
Kharkar et al. [19] reported reduced IENFD in the affected limb in only 20% of CRPS-I patients when using the fifth percentile cutoff value from a normative data set. However, the healthy controls used by Kharkar et al. were not matched with patients by age or gender, as recommended by the European Federation of Neurological Societies [33] . Our patients were matched Figure 3 Cold ratings (A), cold pain ratings (B), heat ratings (C), and heat pain ratings (D) in healthy controls and in the affected limb and the contralateral unaffected limb of CRPS-I patients. Each dot represents data from one participant, and the horizontal line in each column represents the median. *P < 0.05 and **P < 0.01 compared with controls (Mann-Whitney U test) or between the affected and unaffected limb of CRPS-I patients (Wilcoxon signed-ranks test). to the healthy controls by age and gender, which might explain why our results differed from those of Kharkar et al. Nonetheless, even when using a general fifth percentile cutoff value (across gender and age), all our patients met the criteria for reduced IENFD in both extremities.
Another difference between the present study and that of Kharkar et al. [19] is the duration of symptoms. The patients in Kharkar's study had a mean CRPS duration of 5.4 years (range ¼ 0.2-22.8 years) whereas our patient group had experienced CRPS for 9.5 years (range ¼ 4.4 -16.8 years). One might hypothesize that IENFD changes with duration of the disease. However, both in the study by Kharkar et al. [19] and our study, no association was found between the duration of CRPS symptoms and IENFD, suggesting that IENFD does not decrease gradually over time. However, we cannot exclude a floor effect or a weak association that was missed due to the small sample.
Oaklander et al. [18] identified small fiber pathology in the affected limb of the majority of CRPS-I patients (17 of 18 patients, 94.4%) when compared with small fiber distribution at unaffected sites in the ipsilateral and contralateral limb, but did not compare IENFD in CRPS-I and healthy controls. This contrasts with our finding of a bilateral reduction of IENFD in CRPS-I.
It is well documented that CRPS symptoms such as hyperalgesia and edema [34] may spread from the affected limb to ipsilateral and contralateral limbs [16] . In animal models of unilateral CRPS-I, bilateral hyperalgesia and bilateral increases in skin tumor necrosis factor alpha levels have been observed [35, 36] . Similarly, increased bilateral neurogenic flares to transcutaneous electrical stimulation [37] and bilateral increases in substance P-induced plasma protein extravasation [38] have been found in patients with unilateral CRPS-I. We have previously shown a bilateral increase in numbers of skin a1-adrenoceptors in patients with CRPS-I [3] and increased capsaicin-induced pain bilaterally in patients with chronic unilateral CRPS and, consistent with the present findings, normal thermal detection thresholds but bilateral hypersensitivity to thermal stimuli [13] . Taken together, these findings suggest clear bilateral pathology in patients with unilateral CRPS-I. Peripheral nerve injuries provoke bilateral reductions in nerve fiber density [39] , possibly mediated by systemic inflammatory or neurotrophic factors or activation of spinal microglia. However, the mechanisms giving rise to bilateral or potentially widespread small fiber pathology in CRPS-I are unknown.
An important question remains about whether CRPS-I patients or a subset of patients with CRPS-I have idiopathic small fiber neuropathy. The classic distal lengthdependent small fiber neuropathy primarily involves burning feet. The symptoms may gradually progress to involve the distal legs, fingertips, and hands. This traditional distal pattern is often associated with a decreased IENFD of unmyelinated nerves at the distal leg (in approximately 85% of the cases) [23] . However, symptoms and reduced IENFD might be present unilaterally or in upper before lower limbs as described in nonlength-dependent SFN [40] . Indeed, the present clear reduction of small fibers bilaterally is compatible with the notion that small fiber neurodegenerative changes are involved in CRPS-I. It has recently been pointed out that fibromyalgia, a condition of unknown etiology but dominated by widespread pain and hypersensitivity to mechanical stimuli, may be due to small fiber pathology [41, 42] . Whether small fiber pathology is the cause of CRPS or vice versa is unknown. One possibility is that SFN is a predisposing factor for CRPS. Multiple acquired (metabolic, infectious, drugs, toxins, vitamin deficiencies), immune-mediated, neurodegenerative, and genetic conditions are associated with SFN [43] . Thus, a unilateral trauma in a patient with SFN might trigger the development of CRPS and could explain the bilateral findings of small fiber pathology in CRPS-I patients.
Link Between Reduced IENFD and Thermal Sensitivity
Despite a bilateral reduction in IENFD in CRPS-I patients, we did not find abnormal thermal detection thresholds bilaterally. Instead, thermal detection thresholds for both limbs were similar to the thermal detection thresholds of the healthy controls. Only the heat pain threshold in the affected limb differed from that of the healthy controls, consistent with heat hyperalgesia in the affected limb. Likewise, Kharkar et al. [19] found no linear relation between thermal detection thresholds and IENFD in CRPS-I patients. A significant correlation between IENFD and cold and warm detection thresholds in other patient groups with SFN has been described [23, [25] [26] [27] [28] . However, investigators in one of these studies could find no association between IENFD and cold detection thresholds when they changed the test site from the distal leg to the proximal thigh [23] . Similar findings were reported in other studies [29, 30] .
The diagnosis of SFN is a challenge because there is no established gold standard in the clinical setting to demonstrate such nerve fiber involvement. One accepted definition of SFN diagnosis is sensory neuropathy with paresthesias (abnormal sensations) that are typically painful (i.e., dysesthesias), along with abnormal findings of small fiber function in at least one of the following: neurological examination, specialized neurophysiological testing, or skin biopsy [44] . Traditionally, thermal detection thresholds (loss of cold and warmth detection) have been used as part of the neurological examination to diagnose SFN [45] . However, our study raises doubts about the validity of using thermal detection thresholds for this purpose.
In contrast to the normal detection thresholds to thermal stimuli, heat ratings were greater for both the affected and the contralateral limb of patients than healthy controls. This observation is similar to findings of bilateral heat hypersensitivity observed in the study by Terkelsen et al. [13] . In addition, cold and cold pain ratings were greater in the affected limb of patients than in controls, and cold pain ratings were greater in the affected limb than the unaffected limb of patients. It is possible that the evoked response to a thermal stimulus better reflects ongoing pathology than a measure of threshold. However, mechanisms in addition to loss of IENFD appear to contribute to heightened thermal sensitivity in CRPS-I.
Conclusions
Small fiber neuropathology appeared to be present in all of our CRPS-I patients as IENFD was significantly lower both in the affected and unaffected limbs of CRPS-I patients compared with healthy controls. Furthermore, our findings indicate that thermal detection thresholds were not valid indicators of SFN as determined by IENFD. Increased thermal ratings to heat may be better indicators of SFN, but this raises the paradox of heightened sensitivity to thermal stimuli despite loss of intraepidermal nerve fibers.
The strength of our study design is the involvement of a healthy gender-and age-matched control group, and comparison of skin biopsies from the affected limb with an equivalent site on the contralateral unaffected limb of CRPS-I patients and equivalent sites in healthy controls. For ethical reasons, skin biopsies were obtained from only one limb of healthy controls. However, these were likely to be representative, as IENFD was found to be highly correlated at unaffected sites in the ipsilateral and contralateral limbs of CRPS-I patients [18] . Another potential limitation is the sample size. Future studies should include more participants to elucidate the potential difference of IENFD between CRPS-I patients and controls. However, the large difference observed between patients and controls in the present study indicates that this is more than a chance finding.
Skin biopsy with IENFD has been found to be the most reliable tool for diagnosing SFN [43] . However, a limitation of the technique is that the assessments are limited to 3-mm punch biopsies. How these skin samples reflect the skin in the surrounding area is unknown, and profound changes could potentially be missed. Moreover, skin biopsies cannot discriminate between different etiologies or functional consequences of small fiber pathology. The present and previous findings of small fiber degeneration in CRPS-I highlight a need for further studies. In particular, identifying the mechanisms of small fiber pathology in CRPS-I could contribute to an improved understanding of CRPS-I and potentially to improved treatments.
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